Infectious Diseases Completed Phase 4 Trials for Piperacillin (DB00319)
Also known as: Disease, Infectious / Infectious Disease
| Indication | Status | Phase |
|---|---|---|
| DBCOND0028267 (Infectious Diseases) | Completed | 4 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01198925 | Assessment of the Optimal Dosing of Piperacillin-tazobactam in Intensive Care Unit Patients: Extended Versus Continuous Infusion | Treatment |